Hydrochlorothiazide 50 MG Triamterene 75 MG Oral Tablet
INDICATIONS AND USAGE This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. Triamterene and hydrochlorothiazide tablets, USP are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. Triamterene and hydrochlorothiazide tablets, USP are also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked (e.g., patients on concomitant digitalis preparations, or with a history of cardiac arrhythmias, etc.). Triamterene and hydrochlorothiazide tablets, USP may be used alone or in combination with other antihypertensive drugs, such as beta-blockers. Since triamterene and hydrochlorothiazide tablets, USP may enhance the actions of these drugs, dosage adjustments may be necessary. Usage in Pregnancy The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. Edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. Thiazides are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy. Dependent edema in pregnancy, resulting from restriction of venous return by the expanded uterus, is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. There is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema, in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances, this edema may cause extreme discomfort which is not relieved by rest. In these cases, a short course of diuretics may provide relief and may be appropriate.
Zydus Pharmaceuticals (USA) Inc.
Related Pills
Hydrochlorothiazide 25 MG Triamterene 37.5 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
irbesartan and hydrochlorothiazide tablet
west-ward pharmaceuticals corp.
irbesartan and hydrochlorothiazide tablet
west-ward pharmaceuticals corp.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
TRIAMTERENE AND HYDROCHLOROTHIAZIDE Tablets USP, 37.5 mg/25 mg are yellowish green to green colored, spotted, round shaped, flat, uncoated tablets debossed with '856' on one side and breakline on the other side and are supplied as follows: NDC 68382-856-01 in bottles of 100 tablets with child-resistant closure NDC 68382-856-05 in bottles of 500 tablets NDC 68382-856-10 in bottles of 1000 tablets NDC 68382-856-77 in unit-dose blister cartons of 100 tablets (10 X 10 Unit-dose)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE Tablets USP, 75 mg/50 mg are light yellow to yellow colored, round shaped, flat, uncoated tablets debossed with '857' on one side and breakline on the other side and are supplied as follows: NDC 68382-857-01 in bottles of 100 tablets with child-resistant closure NDC 68382-857-05 in bottles of 500 tablets NDC 68382-857-10 in bottles of 1000 tablets NDC 68382-857-77 in unit-dose blister cartons of 100 tablets (10 X 10 Unit-dose) Store at 20º to 25º C (68º to 77º F) [See USP Controlled Room Temperature]. Protect from light. Dispense in a tight, light-resistant container as defined in the USP. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India Distributed by: Zydus Pharmaceuticals ( USA) Inc. Pennington, NJ 08534 Rev.: 11/22
More pills like ROUND 857